Inflammatory breast cancer, best practice in the community setting.

IF 7.6 2区 医学 Q1 ONCOLOGY
Yoko Takahashi, Nithya Sridhar, Toshiaki Iwase, Ashley Marumoto, Jami Fukui, Aiesha Pradhan, Yee Chung Cheng, Naoto T Ueno
{"title":"Inflammatory breast cancer, best practice in the community setting.","authors":"Yoko Takahashi, Nithya Sridhar, Toshiaki Iwase, Ashley Marumoto, Jami Fukui, Aiesha Pradhan, Yee Chung Cheng, Naoto T Ueno","doi":"10.1038/s41523-025-00765-4","DOIUrl":null,"url":null,"abstract":"<p><p>Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer typically diagnosed at advanced stages. Although many cases initially respond to conventional therapies, IBC remains refractory, with high risk of recurrence due to early dissemination, tumor heterogeneity, and complex microenvironmental factors. Despite advancements in treatment, IBC poses unique challenges, particularly in community healthcare settings, where implementation of current guidelines is often limited by disease complexity and evidence gaps. Multidisciplinary care is essential and should include education on therapeutic options, lymphedema management, financial navigations, and ongoing support. To support diagnostic consistency, a consensus-driven IBC Scoring System has been developed to help clinicians identify IBC more accurately using clinical features This paper reviews best practices for managing IBC in community settings, emphasizing practical, multidisciplinary strategies that improve outcomes and presenting a framework aligns with the realities of community healthcare to ensure patients receive the highest possible standard of care.</p>","PeriodicalId":19247,"journal":{"name":"NPJ Breast Cancer","volume":"11 1","pages":"52"},"PeriodicalIF":7.6000,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145426/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Breast Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41523-025-00765-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer typically diagnosed at advanced stages. Although many cases initially respond to conventional therapies, IBC remains refractory, with high risk of recurrence due to early dissemination, tumor heterogeneity, and complex microenvironmental factors. Despite advancements in treatment, IBC poses unique challenges, particularly in community healthcare settings, where implementation of current guidelines is often limited by disease complexity and evidence gaps. Multidisciplinary care is essential and should include education on therapeutic options, lymphedema management, financial navigations, and ongoing support. To support diagnostic consistency, a consensus-driven IBC Scoring System has been developed to help clinicians identify IBC more accurately using clinical features This paper reviews best practices for managing IBC in community settings, emphasizing practical, multidisciplinary strategies that improve outcomes and presenting a framework aligns with the realities of community healthcare to ensure patients receive the highest possible standard of care.

炎性乳腺癌,在社区环境下的最佳实践。
炎症性乳腺癌(IBC)是一种罕见的侵袭性乳腺癌,通常在晚期诊断出来。尽管许多病例最初对常规治疗有反应,但IBC仍然难治性,由于早期传播、肿瘤异质性和复杂的微环境因素,其复发风险很高。尽管在治疗方面取得了进展,但IBC带来了独特的挑战,特别是在社区卫生保健环境中,目前指南的实施往往受到疾病复杂性和证据差距的限制。多学科治疗至关重要,应包括治疗方案教育、淋巴水肿管理、财务指导和持续支持。为了支持诊断的一致性,已经开发了一个共识驱动的IBC评分系统,以帮助临床医生使用临床特征更准确地识别IBC。本文回顾了在社区环境中管理IBC的最佳实践,强调了改善结果的实用的多学科策略,并提出了一个与社区医疗保健现实相一致的框架,以确保患者接受最高标准的护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
NPJ Breast Cancer
NPJ Breast Cancer Medicine-Pharmacology (medical)
CiteScore
10.10
自引率
1.70%
发文量
122
审稿时长
9 weeks
期刊介绍: npj Breast Cancer publishes original research articles, reviews, brief correspondence, meeting reports, editorial summaries and hypothesis generating observations which could be unexplained or preliminary findings from experiments, novel ideas, or the framing of new questions that need to be solved. Featured topics of the journal include imaging, immunotherapy, molecular classification of disease, mechanism-based therapies largely targeting signal transduction pathways, carcinogenesis including hereditary susceptibility and molecular epidemiology, survivorship issues including long-term toxicities of treatment and secondary neoplasm occurrence, the biophysics of cancer, mechanisms of metastasis and their perturbation, and studies of the tumor microenvironment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信